Navigation Links
GeoVax Labs Reports 2012 First Quarter Financial Results
Date:5/15/2012

of Health (NIH). This compares to $893,002 of grant revenue reported for the same period in 2011. As of March 31, 2012, there is approximately $3.3 million in unused IPCAVD grant funds available for use through August 31, 2012 (the end of the original project period).

Research and development (R&D) expenses were $1,072,354 for the three months ended March 31, 2012, compared with $838,467 for the comparable period in 2011. R&D expenses include direct costs funded by the IPCAVD grant, as well as vaccine manufacturing costs and expenses related to the Phase 1/2 clinical trial, being sponsored by GeoVax, of the Company's therapeutic HIV vaccine. Costs associated with the Phase 2a clinical trial of GeoVax's preventative HIV vaccine, being conducted by the HVTN, are being funded directly by the NIH and are therefore not reflected in GeoVax's financial statements. General and administrative (G&A) expenses were $512,818 and $661,813 for the three months ended March 31, 2012 and 2011, respectively.

GeoVax reported cash balances of $2,240,486 at March 31, 2012, as compared to $1,167,980 at December 31, 2011. Summarized financial information is attached. Further information concerning the Company's financial position and results of operations are included in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission.

About GeoVax's TechnologyGeoVax's unique two component vaccine, a recombinant DNA and a recombinant modified vaccinia Ankara (MVA), is designed to stimulate both anti-HIV T cell and anti-HIV antibody immune responses. GeoVax's DNA and MVA vaccines are used in a prime/boost protocol in which priming is done with the DNA and boosting with the MVA. Both the DNA and MVA express the three major proteins of the AIDS virus: Gag, Pol, and Env, and produce non-infectious virus-like-particles. GeoVax's vaccines are unique in expressing virus-like particles that display the trimeric membrane bound form of the HIV-
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
3. GeoVax Phase 2a Clinical Trial Completes Enrollment
4. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
5. GeoVax Labs, Inc. Announces Second Quarter Financial Results
6. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
7. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
8. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
9. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
10. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
11. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 20, 2014 /CNW Telbec/ - KLOX Technologies ... the following appointments: Todd Martensen ... the newly created role of Chief Commercial Officer, to ... using topical photoconverter gel for the treatment of chronic ... traumatic wounds, recently approved in Europe ...
(Date:11/21/2014)... -- Oxis International, Inc. (OXIS) (OXI.PA) announced today the resignation ... J. Cataldo as Chief Executive Officer, and Steven ... Ken Eaton resigned his positions as Chief Executive ... International, Inc. to pursue new opportunities. Mr. ... of Oxis International, Inc. Mr. Cataldo will continue to serve ...
(Date:11/18/2014)... , Nov. 18, 2014 Respiratory Motion and ... leading medical device and services providers in ... for Respiratory Motion,s innovative respiratory depression monitor, the ExSpiron™. ... IMI are working together to connect the clinical community ... long history of bringing innovative medical devices and new ...
Breaking Medicine Technology:KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 2Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 4
... , , ATLANTA ... Health Information Technology for Economic and Clinical Health (HITECH) Act, Elekta ... care centers take advantage of the financial incentives available from the ... new adopters of certified EMR systems who are able to demonstrate ...
... , ALEXANDRIA, Va. , Feb. 4 ... primary lender for a $25 million credit facility provided ... in the transaction. , EUSA Pharma is a specialty pharmaceutical company ... it markets predominately in Europe and the United ...
Cached Medicine Technology:Elekta Expands Consultative Services Program to Help MOSAIQ Customers Demonstrate Meaningful Use Guidelines 2Elekta Expands Consultative Services Program to Help MOSAIQ Customers Demonstrate Meaningful Use Guidelines 3Oxford Finance Corporation Closes $25 Million Credit Facility with EUSA Pharma 2Oxford Finance Corporation Closes $25 Million Credit Facility with EUSA Pharma 3
(Date:11/21/2014)... 2014 Saint Luke’s Mid America ... Guidelines®–Heart Failure Gold-Plus Quality Achievement Award for implementing ... Heart Association/American College of Cardiology Foundation in their ... Get With The Guidelines–Heart Failure is a quality ... most up-to-date, research-based guidelines with the goal of ...
(Date:11/21/2014)... November 21, 2014 Big Bud Farms ... upcoming episode of Innovations with Ed Begley Jr., airing ... times TBA. , Big Bud Farms, growers of legal ... harvesting, and utilization of medical marijuana. , This segment ... Farms’ wide variety of products for medicating. Viewers will ...
(Date:11/21/2014)... November 21, 2014 Recently, VogueQueen ... launched a wedding dress promotion for the coming holiday ... a special offer when checking out. , The beach ... 2014. The customers like the designs for the premium ... would not only be good for the environment, they ...
(Date:11/21/2014)... 2014 Midway through the research period ... (AIS) annual Directory of Health Plans, preliminary data shows ... of Health Plans is a comprehensive resource with enrollment ... the U.S. The 2015 edition will be ... Directory and Databases Division, the company’s exclusive in-house research ...
(Date:11/21/2014)... TruDenta, the creator of a diagnostic and ... jaw-related symptoms, has reported a nationwide rise in the ... neck pain, TMJ (temporomandibular joint) disorder, jaw pain, tinnitus, ... a 52% increase in the number of patients our ... and their teams in 47 states are changing lives ...
Breaking Medicine News(10 mins):Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2Health News:Beach Wedding Dresses on Sale for the Coming Holiday Season at VogueQueen.com 2Health News:Data from Atlantic Information Services’s Forthcoming Directory Shows Volatility in U.S. Health Care Market 2Health News:National Rise In Patients Seeking Headache Relief 2
... associated with an increased risk of sleep disturbance, which ... health, suggests a research abstract that will be presented ... the 25th Anniversary Meeting of the Associated Professional Sleep ... was associated with an elevated risk of self-reported sleep ...
... cutting-edge research that promises to revolutionise the diagnosis and treatment ... used in the long-term to develop a radical new type ... dummy to meet the different needs of individual patients. If ... market within 4 years. The research is being ...
... GALVESTON, Texas More than a thousand years ago, somewhere ... virus that infected mainly monkeys and a large, susceptible group ... of dengue fever. Today, dengue virus which can ... has spread throughout tropical Asia, Africa and South America, and ...
... have identified a new pathway that sets the clock for ... the interaction between a toxic protein called progerin and telomeres, ... tips that bind the ends of shoelaces. The ... (NHGRI) appears in the June 13, 2011 early online edition ...
... controversial aspects of Medicare spending and quality of ... the nation,s largest health services research professional association. ... Article of the Year Award to Jeffrey H. ... Outcomes Research at The Children,s Hospital of Philadelphia, ...
... Guidelines that reduce the use of mechanical ventilation with ... respiratory support can profoundly affect those children,s outcomes while ... of researchers at Children,s Hospital Boston. The ... of Newborn Medicine at Children,s Hospital Boston and the ...
Cached Medicine News:Health News:Sleep problems may be a link between perceived racism and poor health 2Health News:New software 'hearing dummies' pave the way for tailor-made hearing aids 2Health News:New software 'hearing dummies' pave the way for tailor-made hearing aids 3Health News:Researchers warn of 'fever from the forest' 2Health News:Researchers warn of 'fever from the forest' 3Health News:NIH researchers find new clues about aging 2Health News:NIH researchers find new clues about aging 3Health News:NIH researchers find new clues about aging 4Health News:Hospital outcomes research named 'Article of the Year' 2Health News:Hospital outcomes research named 'Article of the Year' 3Health News:Guidelines for ventilator use help premature infants breathe easier 2
... The Stimuplex Dig RC peripheral nerve ... set the pace for peripheral nerve stimulator ... ,NEW! Remote Control Unit. Now available, a ... control device for your Stimuplex Dig. It ...
... A complete system for the delivery and ... INOvent delivery system is a fully integrated, ... inhaled nitric oxide therapy. The INOvent delivery ... ventilator (or anesthesia machine) to deliver a ...
... Although other treatments for ,ED (e.g. Viagra, ... today, ,Vacuum Therapy is ... their physicians ,because of the very positive ... be used as a daily ,exercise to ...
... Mesh Self-Forming Plug is a mesh plug ... well as primary inguinal hernias and femoralhernias. ... defect and fills it completely. Premilene Mesh ... of the established Premilene Mesh. The plug ...
Medicine Products: